selected publications
- Human Placenta-Derived Cells (PDA-002) in Diabetic Foot Ulcer Patients With and Without Peripheral Artery Disease: A Phase 2 Multi-Center, Randomised, Double-Blind, Placebo-Controlled Trial. International wound journal. 2025 Academic Article GET IT
-
Senescence, NK cells, and cancer: navigating the crossroads of aging and disease.
Frontiers in immunology.
2025
Review
GET IT
Times cited: 3 -
Placental circulating T cells: a novel, allogeneic CAR-T cell platform with preserved T-cell stemness, more favorable cytokine profile, and durable efficacy compared to adult PBMC-derived CAR-T.
Journal for immunotherapy of cancer.
2024
Academic Article
GET IT
Times cited: 1 -
A tri-layer decellularized, dehydrated human amniotic membrane scaffold supports the cellular functions of human tenocytes in vitro.
Journal of materials science. Materials in medicine.
2023
Academic Article
GET IT
Times cited: 3 -
Placental-Derived Biomaterials and Their Application to Wound Healing: A Review.
Bioengineering (Basel, Switzerland).
2023
Review
GET IT
Times cited: 21 -
An in vitro comparison of human corneal epithelial cell activity and inflammatory response on differently designed ocular amniotic membranes and a clinical case study.
Journal of biomedical materials research. Part B, Applied biomaterials.
2022
Academic Article
GET IT
Times cited: 11 -
A decellularized flowable placental connective tissue matrix supports cellular functions of human tenocytes in vitro.
Journal of experimental orthopaedics.
2022
Academic Article
GET IT
Times cited: 11 -
The impact of fertilization on the chicken egg yolk plasma and granule proteome 24 hours post-lay at room temperature: capitalizing on high-pH/low-pH reverse phase chromatography in conjunction with tandem mass tag (TMT) technology.
Food & function.
2015
Academic Article
GET IT
Times cited: 13 -
Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study.
Multiple sclerosis and related disorders.
2014
Academic Article
GET IT
Times cited: 107 -
Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study.
Inflammatory bowel diseases.
2013
Academic Article
GET IT
Times cited: 65 -
The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions.
Microvascular research.
2008
Academic Article
GET IT
Times cited: 220